The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections

ecancermedicalscience

Volumn 9, Issue , 2015, Pages

  Mattoscio, Domenico ^a   Casadio, Chiara ^a   Fumagalli, Marzia ^b   Sideri, Mario ^a   Chiocca, Susanna ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b TTFactor Srl   (Italy)

Author keywords

Biomarker; Cervical cancer; HPV; HSIL; LSIL; SUMO; Ubc9

Indexed keywords

BIOLOGICAL MARKER; PROTEIN UBC9; SUMO PROTEIN;

ADULT; AGED; ARTICLE; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PROTEIN EXPRESSION; SUMOYLATION; UPREGULATION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

EID: 84930588519     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2015.534     Document Type: Article

References (40)

1. Moody CA and Laimins LA (2010) Human papillomavirus oncoproteins: pathways to transformation Nat Rev Cancer 10 550-560 DOI: 10.1038/nrc2886 PMID: 20592731
2. Tommasino M (2014) The human papillomavirus family and its role in carcinogenesis Semin Cancer Biol 26 13-21 DOI: 10.1016/j.semcancer.2013.11.002
3. Schiffman M et al (2011) Human papillomavirus testing in the prevention of cervical cancer J Natl Cancer Inst 103 368-383 DOI: 10.1093/jnci/djq562 PMID: 21282563 PMCID: 3046952
4. Carozzi F et al (2008) Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial Lancet Oncol 9 937-945 DOI: 10.1016/S1470-2045(08)70208-0 PMID: 18783988
5. Carozzi F et al (2013) Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial Lancet Oncol 14 168-176 DOI: 10.1016/S1470-2045(12)70529-6
6. Denton KJ et al (2010) The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results Am J Clin Pathol 134 12-21 DOI: 10.1309/AJCP3CD9YKYFJDQL PMID: 20551261
7. Tsoumpou I et al (2009) p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev 35 210-220 DOI: 10.1016/j.ctrv.2008.10.005 PMID: 19261387 PMCID: 2784486
8. Nucci MR and Oliva E (2009) Gynecologic pathology: A volume in the series - foundations in diagnostic pathology
9. Geiss-Friedlander R and Melchior F (2007) Concepts in sumoylation: a decade on Nat Rev Mol Cell Biol 8 947-956 DOI: 10.1038/nrm2293 PMID: 18000527
10. Hay RT (2005) SUMO: a history of modification Mol Cell 18 1-12 DOI: 10.1016/j.molcel.2005.03.012 PMID: 15808504
11. Mattoscio D, Segre CV and Chiocca S (2013) Viral manipulation of cellular protein conjugation pathways: the SUMO lesson World J Virol 2 DOI: 10.5501/wjv.v2.i2.79 PMID: 24175232 PMCID: 3785051
12. Boggio R and Chiocca S (2006) Viruses and sumoylation: recent highlights. Curr Opin Microbiol 9 430-436 DOI: 10.1016/j.mib.2006.06.008 PMID: 16815735
13. Everett RD, Boutell C and Hale BG (2013) Interplay between viruses and host sumoylation pathways Nat Rev Microbiol 11 400-411 DOI: 10.1038/nrmicro3015 PMID: 23624814
14. Citro S and Chiocca S (2013) Sumo paralogs: redundancy and divergencies Front Biosci (Schol Ed) 5 544-553
15. Boggio R and Chiocca S (2005) Gam1 and the SUMO pathway Cell Cycle 4 533-535 DOI: 10.4161/cc.4.4.1605 PMID: 15876861
16. Boggio R et al (2004) A mechanism for inhibiting the SUMO pathway Mol Cell 16 549-561 DOI: 10.1016/j.molcel.2004.11.007 PMID: 15546615
17. Boggio R, Passafaro A and Chiocca S (2007) Targeting SUMO E1 to ubiquitin ligases: a viral strategy to counteract sumoylation J Biol Chem 282 15376-15382 DOI: 10.1074/jbc.M700889200 PMID: 17392274
18. Chiocca S et al (2002) Histone deacetylase 1 inactivation by an adenovirus early gene product Curr Biol 12 594-598 DOI: 10.1016/S0960-9822(02)00720-0 PMID: 11937030
19. Colombo R et al (2002) The adenovirus protein Gam1 interferes with sumoylation of histone deacetylase 1 EMBO Rep 3 1062-1068 DOI: 10.1093/embo-reports/kvf213 PMID: 12393750 PMCID: 1307602
20. Pozzebon ME et al (2013) BC-box protein domain-related mechanism for VHL protein degradation Proc Natl Acad Sci U S A 110 18168-18173 DOI: 10.1073/pnas.1311382110 PMID: 24145437 PMCID: 3831490
21. Heaton PR et al (2011) HPV E6 proteins target Ubc9, the SUMO conjugating enzyme Virus Res 158 199-208 DOI: 10.1016/j.virusres.2011.04.001 PMID: 21510985 PMCID: 3103646
22. Chand V et al (2014) High-risk HPV16E6 stimulates hADA3 degradation by enhancing its SUMOylation Carcinogenesis 35 1830-1839 PMID: 24795430
23. Jaiswal N et al (2014) Oncogenic human papillomavirus 16E7 modulates SUMOylation of FoxM1b Int J Biochem Cell Biol 58C 28-36
24. Ronen O et al (2009) Expression of a novel marker, Ubc9, in squamous cell carcinoma of the head and neck Head Neck 31 845-855 DOI: 10.1002/hed.21048 PMID: 19309722
25. Szendefi M et al (2003) Association between promyelocyte protein and small ubiquitin-like modifier protein and the progression of cervical neoplasia Obstet Gynecol 102 1269-1277 DOI: 10.1016/S0029-7844(03)00845-7 PMID: 14662214
26. Wang Q et al (2013) SUMO-specific protease 1 promotes prostate cancer progression and metastasis Oncogene 32 2493-2498 DOI: 10.1038/onc.2012.250
27. Chen SF et al (2011) Ubc9 expression predicts chemoresistance in breast cancer Chin J Cancer 30 638-644 DOI: 10.5732/cjc.011.10084 PMID: 21880185 PMCID: 4013326
28. Geletu M et al (2007) Target proteins of C/EBPalphap30 in AML: C/EBPalphap30 enhances sumoylation of C/EBPalphap42 via up-regulation of Ubc9 Blood 110 3301-3309 DOI: 10.1182/blood-2007-01-071035 PMID: 17671234
29. Han JY et al (2010) Association of SUMO1 and UBC9 genotypes with tumor response in non-small-cell lung cancer treated with irinotecan-based chemotherapy Pharmacogenomics J 10 86-93 DOI: 10.1038/tpj.2009.46
30. Li H et al (2013) Ubc9 promotes invasion and metastasis of lung cancer cells Oncol Rep 29 1588-1594 PMID: 23381475
31. McDoniels-Silvers AL et al (2002) Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues Neoplasia 4 141-150 DOI: 10.1038/sj.neo.7900217 PMID: 11896569 PMCID: 1550320
32. Mo YY et al (2005) A role for Ubc9 in tumorigenesis Oncogene 24 2677-2683 DOI: 10.1038/sj.onc.1208210 PMID: 15735760
33. Moschos SJ et al (2007) SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas Oncogene 26 4216-4225 DOI: 10.1038/sj.onc.1210216 PMID: 17297476
34. Tomasi ML et al (2012) S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers Hepatology 56 982-993 DOI: 10.1002/hep.25701 PMID: 22407595 PMCID: 3378793
35. Wang S et al (2014) Combined aberrant expression of microRNA-214 and UBC9 is an independent unfavorable prognostic factor for patients with gliomas Med Oncol 31 767 DOI: 10.1007/s12032-013-0767-5
36. Wu F et al (2009) MicroRNA-mediated regulation of Ubc9 expression in cancer cells Clin Cancer Res 15 1550-1557 DOI: 10.1158/1078-0432.CCR-08-0820 PMID: 19223510 PMCID: 2846614
37. Zhao Z et al (2012) MicroRNA-214-mediated UBC9 expression in glioma BMB Rep 45 641-646 DOI: 10.5483/BMBRep.2012.45.11.097 PMID: 23187003 PMCID: 4133799
38. Zhu S et al (2010) Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner Oncogene 29 1763-1772 DOI: 10.1038/onc.2009.459 PMCID: 2845735
39. Agboola AO et al (2014) Clinicopathological and molecular significance of Sumolyation marker (ubiquitin conjugating enzyme 9 (UBC9)) expression in breast cancer of black women Pathol Res Pract 210 10-17 DOI: 10.1016/j.prp.2013.09.011
40. Varadaraj A, Mattoscio D and Chiocca S (2014) SUMO Ubc9 enzyme as a viral target IUBMB Life 66 27-33 DOI: 10.1002/iub.1240 PMID: 24395713